The global OSDF Excipients Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (Powder, Granules, Tablet, Capsule, Dropping Pill), By Application (Hospital, Pharmacy, Others).
Oral solid dosage form (OSDF) excipients play a crucial role in pharmaceutical formulations, providing stability, solubility, and bioavailability to active pharmaceutical ingredients (APIs). The future of the OSDF excipients market is influenced by several key trends, including the growing emphasis on personalized medicine and the increasing demand for novel drug delivery systems. Manufacturers are investing in research and development to create excipients that enable targeted drug delivery and enhance patient compliance. Moreover, regulatory requirements and quality standards are driving the adoption of excipients with improved safety profiles and compatibility with different APIs.
The market report analyses the leading companies in the industry including BASF SE, Calumet Specialty Products Partners, L.P., FMC Corp, Fuji Chemical Industries Co. Ltd, Honeywell International Inc, LyondellBasell Industries N.V., Oxiteno S.A. Indústria e Comércio, Procter & Gamble Co., The Dow Chemical Company.
A significant trend in the market for Oral Solid Dosage Form (OSDF) excipients is the increasing demand for multifunctional excipients. Pharmaceutical manufacturers are seeking excipients that can perform multiple functions within a formulation, such as enhancing drug solubility, improving bioavailability, providing taste-masking properties, and ensuring long-term stability. This trend is driven by the need to streamline the formulation process, reduce development costs, and optimize drug performance. Multifunctional excipients offer a versatile solution to meet these challenges, allowing formulators to achieve desired drug release profiles, overcome formulation barriers, and enhance patient compliance with simplified dosage regimens.
A key driver behind the growth of the OSDF excipients market is the increasing prevalence of chronic diseases worldwide. Conditions such as cardiovascular diseases, diabetes, cancer, and respiratory disorders are on the rise, driving the demand for oral solid dosage forms as preferred treatment options. As the global population ages and lifestyle factors contribute to the growing burden of chronic illnesses, pharmaceutical companies are focusing on developing innovative drug formulations to address unmet medical needs and improve patient outcomes. This growing market for chronic disease therapies is driving the demand for high-quality excipients that can enable the efficient delivery of active pharmaceutical ingredients (APIs) in oral solid dosage forms, thereby fueling the expansion of the OSDF excipients market.
One promising opportunity in the OSDF excipients market lies in catering to the specific needs of pediatric patients. Children often face challenges in swallowing conventional solid dosage forms, leading to issues with medication adherence and efficacy. There is a growing recognition of the importance of developing age-appropriate and palatable formulations for pediatric use, driving the demand for excipients that can facilitate the development of orally dispersible tablets, mini-tablets, granules, and other dosage forms suitable for children. Excipient manufacturers have an opportunity to collaborate with pharmaceutical companies to develop pediatric-friendly formulations that meet regulatory requirements for safety, efficacy, and palatability, addressing a significant unmet need in the pediatric healthcare market and enhancing patient care.
The Tablet segment is the largest in the OSDF (Oral Solid Dosage Form) Excipients Market, primarily due to its widespread use and popularity in pharmaceutical formulations. Tablets are one of the most commonly used dosage forms for oral medications due to potential advantages they offer. tablets are convenient to manufacture, package, and administer, making them a preferred choice for both pharmaceutical companies and patients. Further, tablets allow for precise dosing and accurate drug delivery, ensuring consistent therapeutic outcomes. Additionally, tablets offer stability and ease of storage, facilitating long-term shelf-life and distribution. Furthermore, advancements in excipient technology have enabled the development of various tablet formulations with modified release profiles, allowing for extended drug release, sustained action, and improved patient compliance. As a result of these factors, the Tablet segment dominates the OSDF Excipients Market, holding the largest share in terms of both volume and revenue.
The Hospital segment is the fastest-growing segment in the OSDF (Oral Solid Dosage Form) Excipients Market The increasing prevalence of chronic diseases, rising geriatric population, and expanding healthcare infrastructure drive the demand for oral solid dosage form medications in hospital settings. Hospitals serve as primary centers for acute and chronic disease management, where patients often require immediate and ongoing medication therapy. Further, hospitals prioritize efficiency, patient safety, and cost-effectiveness in medication management, leading to the preference for standardized oral solid dosage forms manufactured with high-quality excipients. Additionally, advancements in pharmaceutical formulations, drug delivery technologies, and therapeutic treatments further accelerate the adoption of oral solid dosage forms in hospital settings. Furthermore, the COVID-19 pandemic has underscored the importance of hospitals in healthcare delivery, leading to increased demand for oral medications to manage symptoms and complications associated with the virus. As hospitals continue to play a pivotal role in healthcare delivery and medication management, the demand for excipients used in oral solid dosage forms is expected to experience sustained acceleration, positioning the Hospital segment as a key driver of growth in the OSDF Excipients Market.
By Type
Powder
Granules
Tablet
Capsule
Dropping Pill
By Application
Hospital
Pharmacy
Others
Regions Included
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
BASF SE
Calumet Specialty Products Partners, L.P.
FMC Corp
Fuji Chemical Industries Co. Ltd
Honeywell International Inc
LyondellBasell Industries N.V.
Oxiteno S.A. Indústria e Comércio
Procter & Gamble Co.
The Dow Chemical Company
*- List Not Exhaustive
TABLE OF CONTENTS
1 Introduction to 2024 OSDF Excipients Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global OSDF Excipients Market Size Outlook, $ Million, 2021 to 2030
3.2 OSDF Excipients Market Outlook by Type, $ Million, 2021 to 2030
3.3 OSDF Excipients Market Outlook by Product, $ Million, 2021 to 2030
3.4 OSDF Excipients Market Outlook by Application, $ Million, 2021 to 2030
3.5 OSDF Excipients Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of OSDF Excipients Industry
4.2 Key Market Trends in OSDF Excipients Industry
4.3 Potential Opportunities in OSDF Excipients Industry
4.4 Key Challenges in OSDF Excipients Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global OSDF Excipients Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global OSDF Excipients Market Outlook by Segments
7.1 OSDF Excipients Market Outlook by Segments, $ Million, 2021- 2030
By Type
Powder
Granules
Tablet
Capsule
Dropping Pill
By Application
Hospital
Pharmacy
Others
8 North America OSDF Excipients Market Analysis and Outlook To 2030
8.1 Introduction to North America OSDF Excipients Markets in 2024
8.2 North America OSDF Excipients Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America OSDF Excipients Market size Outlook by Segments, 2021-2030
By Type
Powder
Granules
Tablet
Capsule
Dropping Pill
By Application
Hospital
Pharmacy
Others
9 Europe OSDF Excipients Market Analysis and Outlook To 2030
9.1 Introduction to Europe OSDF Excipients Markets in 2024
9.2 Europe OSDF Excipients Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe OSDF Excipients Market Size Outlook by Segments, 2021-2030
By Type
Powder
Granules
Tablet
Capsule
Dropping Pill
By Application
Hospital
Pharmacy
Others
10 Asia Pacific OSDF Excipients Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific OSDF Excipients Markets in 2024
10.2 Asia Pacific OSDF Excipients Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific OSDF Excipients Market size Outlook by Segments, 2021-2030
By Type
Powder
Granules
Tablet
Capsule
Dropping Pill
By Application
Hospital
Pharmacy
Others
11 South America OSDF Excipients Market Analysis and Outlook To 2030
11.1 Introduction to South America OSDF Excipients Markets in 2024
11.2 South America OSDF Excipients Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America OSDF Excipients Market size Outlook by Segments, 2021-2030
By Type
Powder
Granules
Tablet
Capsule
Dropping Pill
By Application
Hospital
Pharmacy
Others
12 Middle East and Africa OSDF Excipients Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa OSDF Excipients Markets in 2024
12.2 Middle East and Africa OSDF Excipients Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa OSDF Excipients Market size Outlook by Segments, 2021-2030
By Type
Powder
Granules
Tablet
Capsule
Dropping Pill
By Application
Hospital
Pharmacy
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
BASF SE
Calumet Specialty Products Partners, L.P.
FMC Corp
Fuji Chemical Industries Co. Ltd
Honeywell International Inc
LyondellBasell Industries N.V.
Oxiteno S.A. Indústria e Comércio
Procter & Gamble Co.
The Dow Chemical Company
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Type
Powder
Granules
Tablet
Capsule
Dropping Pill
By Application
Hospital
Pharmacy
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global OSDF Excipients is forecast to reach $1129.6 Million in 2030 from $810 Million in 2024, registering a CAGR of 5.7%
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
BASF SE, Calumet Specialty Products Partners, L.P., FMC Corp, Fuji Chemical Industries Co. Ltd, Honeywell International Inc, LyondellBasell Industries N.V., Oxiteno S.A. Indústria e Comércio, Procter & Gamble Co., The Dow Chemical Company
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: Revenue (USD); Volume